FDA Approves Geron’s Rytelo For Treatment Of Lower-Risk MDS Anemia

(RTTNews) – Geron Corp. (GERN) said that the U.S. Food and Drug Administration has approved Rytelo (imetelstat) for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes or MDS with transfusion-dependent or TD anemia requiring four or more re